Miriplatin is a platinum-based antineoplastic agent belonging to the platinum complex class, primarily utilized as a lipophilic chemotherapy drug for the treatment of hepatocellular carcinoma. It functions… Read more
Miriplatin is a platinum-based antineoplastic agent belonging to the platinum complex class, primarily utilized as a lipophilic chemotherapy drug for the treatment of hepatocellular carcinoma. It functions by inhibiting DNA replication through intercalation and cross-linking, inducing programmed cell death in malignant tumor cells. This category features essential Miriplatin reference standards, including related process impurities, degradation products, and metabolites, which are critical for comprehensive pharmaceutical analysis. These high-quality compounds are employed by analytical laboratories for impurity profiling, method validation, and rigorous quality control protocols during the synthesis and formulation of the drug. By utilizing these characterized standards, researchers can accurately identify, quantify, and monitor potential contaminants throughout the drug development lifecycle, ensuring compliance with regulatory standards and maintaining the integrity of platinum-based therapeutic assessments.